|
1.Abou-Raya., Naim, A. and Marzouk, S. Cardiac matrix remodelling in congestive heart failure: the role of matrix metalloproteinases. Clin.Invest. Med. 27: 93- 100,2004. 2.Altieri,P. , Brunelli, C., Garibald, S., Nicolino, A.,Ubaldi, S, ,spallarossa, P., Olivotti, L., rossettin, P., Barsotti, A . and Ghigliotti, G. Metalloproteinases 2 and 9 are increased in plasma of patients with heart failure. Eur. J. Cllin. Invest. 33: 648-656, 2003. 3.Beatriz-Alvarez, M.D., Garmen-ruiz, M.D., Pilar-Chacon M. D, Jose Alvarez, M.D., Carmen-Ruiz, M.D. Serum values of metalloproteinase-2 and metalloproteinase-9 as related to unstable plaque and inflammatory cellas in patients with greater than 70% varotid artery stenosis. J Vasc. Surg. 40: 469-475, 2004. 4.Caulfield, J . b. and Borg, T.K The collagen network of the heart. Lab. Invest. 40: 364-372, 1979 5.Cheung, P.Y., Sawicki, G. and Wozniak, M. Matrix metalloproteinase-2contributes to ischemia-reperfusion injuryinrhw heart. Circulatio101: 1833-1839, 2000. 6.Etoh, T., Joffs, C. and Deschamps, A. M. Myocardial and interstitial matrix metalloproteinase activity after acute myocardial infarction in pig. Am. J. Physiol. Heart Circ. Physiol. 281: H987-H994, 2001. 7.Fernandez-Patron, C., Martinez-Cuesta, M. A., Salas, E., Sawicki, G., Wozniak,M. and Rado, M.W. Differential regulation of platelet aggregation by Matrix metalloproteinases-9 and -2. Thromb. Haemost. 82: 1730- 1735, 1999. 8.Gaudron, P., Eilles, C., Kugler, I and Ertl, G. Progressive left ventricular dysfunction and remodeling after myocardial infarction: potential mechanisms and early predictors. Circulation 87: 755-763, 1993. 9.Inkubo, Y., Hanada, H and Inshizaka, H. plasma levels of Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1are increased in the coronary circulation in patients with acute coronary syndrome. Am. Heart J. 141: 211-217, 2001. 10.Jugdutt, B. I. Prevention of Ventricular remodeling post myocardial infarction: timing and duration of therapy. Can. J. Cardiol. 9: 103-114, 1993. 11. Jugdutt, B. I. Ventricular remodeling after infarction and the extracellular cpllagen , Matrix : when is enough enough? Circulation 108:1395-1043,2003. 11.Kaden, J. J., Dempfle, C.E. and Sueselbeck,T. Time- dependent changes in the plasma concentration of matrix metalloproteinase 9 after acute myocardial infarction. Cardiology 99:140-144, 2003. 12.Kai, H., Ikeda, H., Yasukawa, H., Kai, M., Seki, Y. and kuwahara, F. Peripheral blood levels of matrid metalloprotinases-2and-9 are elevated in patients with acute coronary syndromes. J. Am. Coll cardiol. 32: 368- 372, 1998. 13.Lu, L., Gunja-Smith, Z. and Woessner, J. F. Matrix metalloproteinase and collagen ultrastructure in moderate myocardial ischemia and reperfusion in vivo. Am. J. Physiol. Heart Circ. Physiol. 279: H601-H609, 2000. 14.Nishikawa, N., Yamamoto, K. and Sakata, Y. Differential activation of Matrix metalloproteinases in heart failure with and without ventiicular dilation. Cardiovasc Res. 57: 766-774, 2003. 15.Peterson, J. T., Li, H. and Dillon, L. Ecolution of Matrix metalloproteinase and tissue inhibitor during heart failure progress-sion in infracted rat. Cardiovasc. Res. 46: 307-315, 2000. 16.Pfeffer, M. A. and Braunwald, E. Ventricular remodeling after myocardial infarction: experimental observatiobns and clinical implications. Circulation81:1161-1172, 1990. 17.Piorlo, J. S., Hutchins, G. M. and Moore, G. W. Infarct expansion: pathologic analysis of 204 patients with a single myocardial infarct. J. Am. Coll Cardiol. 7: 349- 354,1986. 18.Romanic, A. M., Burns-kurtis, C. I. and Gout, B. Matrix metalloproteinase in cardiac myocytes follow myocardial infarction in the rabbit . Life Sci. 68: 799-814, 2001.
19.Rosemberg, G. A., Navartil, M, Barone, F. and Feuerstein, G. Proteolytic cascade enzymes increase in focal cerebral ischemia in rat. J. cereb. Blood flow Metab. 16: 360-366, 1996. 20.Sato, S., Ashraf, M. and Millard, R. W. Connective tissue changes in earlyinchemia of porcine myocardium:an ultrasuructural study. J. Mol. Cell Cardial. 15: 261-275, 1983. 21.Schwartzkopff, B., Fassbach, M., Pelzer, B., Brehm, M. and Strauer, B. E. Elevated serum markers of collagen degradation in patients with mild to moderate dilated cardiomyopathy . Eur. J. Heart Fail. 4: 439-445, 2002.
|